The 7 Longevity Markers Your Annual Physical Doesn't Test For
Most annual physicals are designed to catch disease, not aging.
The standard panel — basic metabolic, lipid profile, CBC, maybe a TSH if someone thinks to check — was built around decades-old thresholds that flag problems once they've arrived. Normal means "not yet sick." It tells you very little about the trajectory you're on.
That's a gap worth understanding, because the last twenty years of longevity research have identified a different set of markers — ones that move years or decades before disease appears. These markers don't diagnose anything. What they do is describe your pace. How fast your cardiovascular system is aging. How inflamed your tissues are at a baseline level. How well your mitochondria are still keeping up.
Seven of them stand out as worth knowing. Not because they predict everything, but because each one gives you specific information about a specific biological system — and each one is modifiable once you see the number.
The Seven Markers
Apolipoprotein B (ApoB)
Your standard lipid panel reports LDL-C — the cholesterol content of your LDL particles. ApoB measures something different and more precise: the number of atherogenic particles circulating in your blood. Every LDL, VLDL, and IDL particle carries exactly one ApoB molecule, so the count is direct.
Why it matters: two people can have identical LDL-C numbers but very different particle counts. The person with more, smaller particles carries substantially higher cardiovascular risk — and standard labs would miss it entirely. A large body of research, including analysis from Sniderman and colleagues, has established that ApoB outperforms LDL-C as a predictor of cardiovascular events.¹
Cardiovascular disease remains the leading cause of death globally. ApoB is the single most informative blood marker you can run for understanding your long-term risk.
Optimal: < 80 mg/dL. Aggressive (for those with risk factors): < 60 mg/dL. Standard "normal" ranges go much higher and are calibrated for disease, not prevention.
Lipoprotein(a) — Lp(a)
Lp(a) is an LDL-like particle with an additional protein wrapped around it, and its level in your blood is roughly 80–90% determined by genetics.² Unlike most lipid markers, it barely moves with diet or exercise. But it matters enormously — elevated Lp(a) is an independent risk factor for heart attack, stroke, and aortic valve disease.
The public health case for testing is straightforward: roughly one in five people worldwide has clinically elevated Lp(a), and almost none of them know it. Because it's genetic, you only need to measure it once in your adult life. The number doesn't change.
What you do with the information depends on the level. High Lp(a) doesn't mean disease is certain — it means other risk factors become more important to manage, because the baseline is already loaded.
Desirable: < 30 mg/dL (or < 75 nmol/L depending on units). Elevated: > 50 mg/dL. Testing once in adulthood is sufficient for most people.
High-Sensitivity C-Reactive Protein (hs-CRP)
Chronic low-grade inflammation sits underneath most age-related diseases — cardiovascular, metabolic, neurodegenerative, and certain cancers. hs-CRP is the most validated general-purpose blood marker for tracking it. It's not specific to any one condition, which is part of what makes it useful: it tells you something systemic about the terrain.
Ridker and colleagues' work established CRP as an independent predictor of cardiovascular events, adding information beyond traditional risk factors.³ Beyond heart disease, elevated chronic inflammation has been linked to accelerated cognitive aging and increased dementia risk.
Context matters for interpretation. CRP temporarily rises during infections, injuries, and after intense exercise, so a single elevated reading shouldn't be over-interpreted. A consistent baseline over multiple readings, measured when you're not acutely ill, is the real signal.
Optimal: < 1.0 mg/L. Moderate risk: 1.0–3.0 mg/L. High: > 3.0 mg/L. A reading above 10 mg/L usually reflects acute illness rather than chronic inflammation.
HbA1c — Tracked Over Years
Hemoglobin A1c reflects your average blood glucose over the previous two to three months. It's already on many annual panels, but the way it's typically used — a single number compared to a disease threshold — misses most of what it can tell you.
The real value comes from tracking the number across years. An HbA1c of 5.4 today may look normal in isolation, but if five years ago it was 5.0, the trajectory is the important data point. Gradual drift within the "normal" range is how metabolic dysfunction develops, and the intervention window is years before a diabetes diagnosis.⁴
Pair HbA1c with a fasting insulin test when possible. Together they reveal insulin resistance earlier than either alone — the point where lifestyle change still has maximum leverage.
Optimal: < 5.4%. Pre-diabetic: 5.7–6.4%. Diabetic: ≥ 6.5%. More important than the current number: the trend across multiple years.
VO2 Max
VO2 max measures the maximum volume of oxygen your body can use during intense exercise. It's a composite marker — reflecting heart, lung, vascular, muscular, and mitochondrial health all at once — and among all measurable health variables, it has one of the strongest associations with all-cause mortality.
A large cohort study by Mandsager and colleagues, analyzing over 120,000 patients, found that cardiorespiratory fitness was associated with reduced mortality risk across every age group, with no observed upper limit to the benefit.⁵ People in the lowest fitness quintile had mortality risk comparable to being a smoker with established heart disease.
Unlike most longevity markers, VO2 max responds dramatically to training. Zone 2 cardio over months and high-intensity intervals over weeks both produce measurable gains. Few other interventions move the needle on lifespan this reliably.
Strongly age- and sex-dependent. Broadly: "Above average" for your age-sex group carries meaningfully lower mortality risk than "average." Lab testing is most accurate; wearable estimates provide a useful trend.
Grip Strength
Grip strength — measured with a handheld dynamometer — is an unexpectedly powerful marker. It correlates with total muscle mass, functional capacity, fall risk, and, across multiple large studies, all-cause mortality.⁶
The logic: muscle mass is one of the most predictive indicators of biological age in the later decades of life. Low grip strength signals low overall muscular capacity, which signals reduced metabolic reserve, reduced functional independence, and increased frailty risk. It's a five-second measurement that captures a lot of information.
Like VO2 max, it's highly modifiable. Resistance training — even simple compound movements performed two to three times per week — reliably improves grip strength and, more importantly, the underlying muscular health it reflects.
Sex- and age-normed. For a rough benchmark: men below ~30 kg or women below ~20 kg on a dominant-hand max grip are in a range associated with elevated mortality risk. Many gyms and physical therapy clinics can measure it.
Insulin-Like Growth Factor 1 (IGF-1)
IGF-1 is a hormone produced largely by the liver in response to growth hormone. It's essential for tissue repair, muscle maintenance, and cognitive function, but its relationship with longevity is genuinely complex — and that's what makes it worth understanding.
The research suggests a U-shaped relationship. Very low IGF-1 is associated with frailty, cognitive decline, and increased mortality in older adults. Very high IGF-1 has been linked to increased cancer risk and may accelerate certain aging pathways.⁷ The healthiest range appears to be the middle — neither deficient nor excessive.
Most people don't need to manipulate IGF-1 directly. Knowing where you fall is useful context for other decisions: if your IGF-1 is already at the top of the range, certain interventions that elevate it further warrant more caution. If it's low, protein intake, resistance training, and sleep quality are the first levers to consider.
Varies significantly by age and reference lab. Most adults want to be in the middle third of the age-adjusted range — not the floor, not the ceiling.
What gets measured gets managed. What doesn't get measured becomes a surprise decades later.
How to Actually Use This
Running every marker on this list would cost several hundred dollars and — more importantly — wouldn't be the right move for most people. The real value is in building a personal baseline over time, tracking the markers most relevant to your situation, and using the data to inform concrete decisions.
The highest-leverage first tests
If you can only add two markers to your next physical, make them ApoB and Lp(a). Together they give you a far more accurate cardiovascular risk picture than the standard lipid panel alone, and Lp(a) is a once-in-a-lifetime test.
After that, hs-CRP and tracked HbA1c fill in the metabolic and inflammatory picture. These four can be added to most standard blood draws for modest additional cost.
Data without action is just anxiety
The point of measuring isn't to collect numbers — it's to decide what to change. High ApoB usually means addressing diet, exercise, and potentially medication. Elevated hs-CRP points at sleep, stress, body composition, or hidden infection. Drifting HbA1c calls for insulin-sensitizing behaviors.
Share the results with a physician who thinks preventively. Most standard reference ranges are calibrated for disease thresholds, not optimal aging. The interpretation matters as much as the measurement.
The biology of aging happens in the gap between "normal" and "sick." Longevity markers exist to measure that gap — so you can see what's happening and act before a standard lab result gives you no other choice.
The Trajectory Is the Point
It's tempting to think of these markers as a test you pass or fail. That framing misses what they're actually for. Every one of them describes a rate — how fast something is changing, how inflamed, how metabolically stressed, how fit. The number matters less than the direction, and the direction matters less than what you're doing about it.
The last decade has made something quietly clear: aging is not a single process. It's a set of parallel trajectories, each one measurable, each one modifiable. You don't have to track them all to benefit. But knowing where you actually stand on a few of the big ones changes what the next decade looks like — and that's the entire point.
Get the Simple, "Plain Talk" Healthy-Aging Guide — Free
A deeper framework for what's actually happening as you age and, more importantly, what to do about it.
Download the Free Guide →1. Sniderman, A.D. et al. "Apolipoprotein B particles and cardiovascular disease: A narrative review." JAMA Cardiology, 2019.
2. Kronenberg, F. et al. "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: A European Atherosclerosis Society consensus statement." European Heart Journal, 2022.
3. Ridker, P.M. "A test in context: High-sensitivity C-reactive protein." Journal of the American College of Cardiology, 2016.
4. American Diabetes Association. "Classification and diagnosis of diabetes: Standards of medical care in diabetes." Diabetes Care, ongoing.
5. Mandsager, K. et al. "Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing." JAMA Network Open, 2018.
6. Leong, D.P. et al. "Prognostic value of grip strength: Findings from the PURE study." The Lancet, 2015.
7. Milman, S. et al. "Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity." Aging Cell, 2014.
© 2026 Igniton™ · www.igniton.com
